The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Moderate Alcohol Intake Decreases SLE Risk in Women

Moderate Alcohol Intake Decreases SLE Risk in Women

March 8, 2017 • By Arthritis Care & Research

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Certain modifiable environmental factors, such as oral contraceptives use and crystalline silica exposure, are associated with an increased risk for systemic lupus erythematosus (SLE) in genetically susceptible individuals. However, the influence of alcohol use on SLE risk has not yet been determined, with conflicting results from previous studies. Alcohol is known to contain elements that suppress systemic inflammation and decrease the synthesis of proinflammatory cytokines, such as tumor necrosis factor, interleukin (IL) 6 and IL-8. And prior research has linked alcohol use to reduced risks for cardiovascular disease and rheumatoid arthritis.

You Might Also Like
  • Moderate Alcohol Use Could Be Safe with Methotrexate for RA
  • History of Depression Is a Risk Factor for SLE in Women
  • SLE Is a Leading Cause of Death Among Women

To investigate a possible association between alcohol consumption and SLE, Medha Barbhaiya, MD, MPH, and colleagues from the Department of Medicine, Division of Rheumatology, Immunology and Allergy at the Brigham and Women’s Hospital conducted a prospective cohort analysis in women, hypothesizing that “long-term moderate alcohol consumption, compared with no alcohol consumption, is associated with decreased risk of SLE.” The results of their research were published in the March 2017 issue of Arthritis Care & Research.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Researchers analyzed information from 204,055 women participating in the Nurses’ Health Study (NHS) (1980–2012) and NHSII (1989–2011) cohorts. At baseline, all participants were free from connective tissue disease and provided information on their personal alcohol consumption. Further alcohol consumption was measured using semiquantitative food frequency questionnaires, which were completed every two to four years and included measurements for beer, wine and hard liquor.

The Results
“We found a robust inverse association between alcohol consumption and SLE risk,” write the authors in their discussion. “These analyses demonstrated a 39% reduction in SLE risk among women who consumed … approximately one-half drink per day.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

As a secondary analysis, researchers examined the effect of alcohol by beverage type. Participants who drank two or more servings of wine per week demonstrated a significantly reduced SLE risk ([95% CI 0.45–0.96], P<0.03 for trend) vs. non-wine drinkers. A similar, but weaker, trend toward an inverse association was also shown for those who consumed two or more servings of beer per week compared with non-beer drinkers (HR 0.71 [95% CI 0.42–1.20], P<0.19 for trend). However, no association was demonstrated between cumulative hard liquor consumption and SLE risk.

An inverse relationship between alcohol intake and SLE risk is “biologically possible,” according to the researchers. Despite the study’s implications for a reduced risk of SLE with moderate alcohol consumption, the authors conclude that potential benefits among pre- and postmenopausal women have to be weighed against possible health risks, specifically the increased risk for cancer even with light to moderate alcohol consumption.

Read the full article.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Barbhaiya M, Lu B, Sparks JA, et al. Influence of alcohol consumption on the risk of systemic lupus erythematosus among women in the Nurses’ Health Study Cohorts. Arthritis Care Res (Hoboken). 2016 Jun 6. doi: 10.1002/acr.22945. [Epub ahead of print]

Pages: 1 2 | Multi-Page

Filed Under: Conditions, SLE (Lupus)

You Might Also Like:
  • Moderate Alcohol Use Could Be Safe with Methotrexate for RA
  • History of Depression Is a Risk Factor for SLE in Women
  • SLE Is a Leading Cause of Death Among Women
  • Does PTSD Increase Risk of RA for Women?

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)